schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
.
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010..
.
..
.. to add a comment. registration is free, and takes less than a minute.